In partnership with The Mason Foundation (managed by Equity Trustees), NFMRI will be seeking Expressions of Interest for projects investigating potential treatments and/or cure for Alzheimer’s Disease.
Funding is available to support research projects, over up to three years, investigating potential causes, treatments and/or a cure for Alzheimer’s disease. The funding will commence in early to mid 2019.
Expressions of interest (EOIs) in portfolios 1, 2 and 3 will be accepted:
Original innovation and discovery not competitive for major grants such as the NHMRC or ARC. This portfolio includes frontier research, early discoveries, new paradigms and early career researchers that need support to become competitive.
Support for strategic collaborative research activities that focus on advancing research and validating directions. Funding is designed to provide access to additional research skills not available through currently available funding or within the research institute.
Support to help bridge the ‘valley of death’. This is the area where research is required to attract and compete for potential investors and collaborators. Funding mechanisms often do not support or encourage contract or non-academically interesting research activities necessary to answer critical research questions.
Funding & Duration
Award amount and duration not supplied. The NFMRI Impact Giving Guide provides a rough guideline of maximum amounts for each portfolio.
Funding is provided for specific research activities associated with this project rather than salaries. Project costs may include a component for support staff, but the Foundation will not support salary costs for the Chief Investigator.
Refer to the Guide for Applicants [PDF] for details.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 24 May 2018
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review